[go: up one dir, main page]

AU2002229434A1 - Controlled release microsphere system for administration of drug to the eye - Google Patents

Controlled release microsphere system for administration of drug to the eye

Info

Publication number
AU2002229434A1
AU2002229434A1 AU2002229434A AU2002229434A AU2002229434A1 AU 2002229434 A1 AU2002229434 A1 AU 2002229434A1 AU 2002229434 A AU2002229434 A AU 2002229434A AU 2002229434 A AU2002229434 A AU 2002229434A AU 2002229434 A1 AU2002229434 A1 AU 2002229434A1
Authority
AU
Australia
Prior art keywords
administration
eye
drug
controlled release
release microsphere
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002229434A
Inventor
Bernard B. Fresco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002229434A1 publication Critical patent/AU2002229434A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU2002229434A 2001-01-29 2002-01-29 Controlled release microsphere system for administration of drug to the eye Abandoned AU2002229434A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26429001P 2001-01-29 2001-01-29
US60/264,290 2001-01-29
PCT/CA2002/000086 WO2002060486A2 (en) 2001-01-29 2002-01-29 Controlled release microsphere system for administration of drug to the eye

Publications (1)

Publication Number Publication Date
AU2002229434A1 true AU2002229434A1 (en) 2002-08-12

Family

ID=23005380

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002229434A Abandoned AU2002229434A1 (en) 2001-01-29 2002-01-29 Controlled release microsphere system for administration of drug to the eye

Country Status (2)

Country Link
AU (1) AU2002229434A1 (en)
WO (1) WO2002060486A2 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276284A (en) * 1971-07-26 1981-06-30 Brown Stuart I Prevention of collagenase induced disease by treatment with collagenase inhibitors
GB2237510B (en) * 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
US5185152A (en) * 1990-01-10 1993-02-09 Peyman Gholam A Method and apparatus for controlled release drug delivery to the cornea and anterior chamber of the eye
DE4038887A1 (en) * 1990-12-06 1992-07-02 Lohmann Therapie Syst Lts METHOD FOR THE PRODUCTION OF COLLAGEN PARTICLES AND THEIR USE AS AN ACTIVE SUBSTANCE
US5462739A (en) * 1991-11-21 1995-10-31 Yeda Research And Development Co., Ltd. Microdelivery device and method for enhanced drug administration to the eye
EP0646000A4 (en) * 1992-11-16 1997-05-02 Univ Mercer Compositions using microencapsulated neutralizing antibodies.
US5612027A (en) * 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US6042820A (en) * 1996-12-20 2000-03-28 Connaught Laboratories Limited Biodegradable copolymer containing α-hydroxy acid and α-amino acid units

Also Published As

Publication number Publication date
WO2002060486A2 (en) 2002-08-08
WO2002060486A3 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
AU2002247381A1 (en) Controlled morphologies in polymer drug for release of drugs
AU2003301957A1 (en) Administration of anti-inflammatory drugs into the central nervous system
AU2002244881A1 (en) Controlled release drug delivery system of pravastatin
AU2002258563A1 (en) Pharmaceutical formulations for sustained release
AU4013900A (en) Increasing cerebral bioavailability of drugs
NO995753D0 (en) Controlled release gastro-retardant microspheres for improved drug administration
AU5335698A (en) Pharmaceutical formulations with delayed drug release
AU5914999A (en) Controlled release drug delivery
AU6008499A (en) Controlled drug release system of retinoic acid
AU2002348242A1 (en) Medication adherence system
AU2001298061A1 (en) Microencapsulation of drugs by solvent exchange
AU2002217373A1 (en) Controlled release pharmaceutical formulation containing venlafaxine
EP1404405A4 (en) IMPLANTABLE MINIATURE MATRIX AND STIMULATION SYSTEM CON US FOR THE STIMULATION OF THE EYE
AU2003287640A1 (en) Inertial drug delivery system
AU2001283359A1 (en) Drug release (delivery system)
AU2002321199A1 (en) Transdermal therapeutic system (TTS) with fentanyl as active ingredient
AU2002343555A1 (en) Eutectic-based self-nanoemulsified drug delivery system
EP1189597A4 (en) Oil-core compositions for the sustained release of hydrophobic drugs
AU2002360717A1 (en) Controlled release dosage form having improved drug release properties
AU2002353435A1 (en) Medication administration system
AU2001232948A1 (en) Controlled release of drugs
AUPR951501A0 (en) Modified sustained release pharmaceutical system
AU2001227030A1 (en) Pharmaceutical composition for controlled release of an active ingredient
AU5820900A (en) Capsule for the controlled release of active substances
AU2002351388A1 (en) Methods and compositions for controlled release of drugs

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase